Patient‐specific quality assurance for extremely small field sizes using 3D in vivo dosimetry in fractionated stereotactic radiosurgery for brain metastases
In pre-treatment QA for brain fSRS, 3D in vivo dosimetry based on DVH analysis demonstrated superior error detection sensitivity compared to conventional 2D gamma analysis. Our results suggest that 3D in vivo dosimetry is a useful tool for pre-treatment QA in brain fSRS.
Authors
- Tatsuya Inoue (ORCID: https://orcid.org/0000-0003-0001-7921)
- Noriyuki Okonogi (ORCID: https://orcid.org/0000-0002-9486-1922)
- Kotaro Iijima (ORCID: https://orcid.org/0000-0003-1691-0175)
- Jun Takatsu (ORCID: https://orcid.org/0000-0001-9848-9251)
- Ruiheng Fan (ORCID: https://orcid.org/0000-0003-0328-2472)
- Naoya Murakami (ORCID: https://orcid.org/0000-0003-0660-9987)
- Naoya Hara
- Naoto Shikama
- Risa Shimomura
- Kenichi Jumonji
Institutions
- Juntendo University (JP)
- Juntendo University Urayasu Hospital (JP)
- Juntendo University Hospital (JP)
- Tokyo Rosai Hospital (JP)
Publication Details
- Journal
- Journal of Applied Clinical Medical Physics
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1002/acm2.70417
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00